Dhaka, Oct. 13 -- On Sept 22, Sinovac wrote to the health minister saying they were planning to begin the phase 3 test of vaccine candidate, CoronaVac, in August. But the firm spent the funds in another country as the Bangladesh government had delayed giving the go-ahead to the trials.

Sinovac said it was not sure about getting the final approval from Bangladesh. They appealed to the Coalition for Epidemic Preparedness Innovation or CEPI for funds to run the trial in Bangladesh but never received it.

So, they need the Bangladesh government to invest money to run the safety trial, the Beijing-based drug maker added.

Sinovac should run the trial with their own money because that's what they said they would do when they had sought approva...